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Background: “Quorum sensing” (QS) is the phenomenon which allows single bacterial cells to measure the
concentration of bacterial signal molecules. Two principle different QS systems are known, the Autoinducer 1
system (AI-1) for the intraspecies communication using different Acyl-homoserine lactones (AHL) and AI-2 for the
interspecies communication. Aim of this study was to investigate QS of Escherichia coli Nissle 1917 (Mutaflor).
Results: While E. coli Nissle is producing AI-2 in a density dependent manner, no AI-1 was produced. To study the
effect of AI-2 in the DSS (dextran sulphate sodium) induced mouse model of acute colitis, we silenced the
corresponding gene luxS by intron insertion. The mutant bacterium E. coli Nissle::luxS was equally effective in
colonizing the colon and the mutation turned out to be 100% stable during the course of the experiment. Isolating
RNA from the colon mucosa and performing semiquantitative RT PCR, we were able to show that the expression of
the pro-inflammatory cytokine IFN-y was suppressed in mice being infected with the E. coli Nissle wild type. Mice
infected with the E. coli Nissle::luxS mutant showed a suppressed expression of IL-10 compared to uninfected mice,
while the expression of the pro-inflammatory cytokines IL-6 and TNF-α was higher in these mice. The expression of
mBD-1 was suppressed in mice being infected with the mutant in comparison to the mice not infected or infected
with the wild type. No differences were seen in the histological examination of the colon sections in the different
groups of mice.
Conclusions: E. coli Nissle is producing AI-2 molecules, which are influencing the expression of cytokines in the
mucosa of the colon in the DSS mice. However, if QS has a direct influence on the probiotic properties of E. coli
Nissle remains to be elucidated.
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The communication of bacteria with each other is
termed “quorum sensing” (QS) [1]. It is an important
global gene regulatory mechanism, which is used by
gram-negative as well as gram-positive bacteria, enabling
individual bacteria to communicate and coordinate their
behavior in populations. In general terms, it is often
defined as cell density-dependent regulation of gene ex-
pression via extracellular signals. Bacteria produce small,
diffusible signals, termed “autoinducers”. When these
signals reach a critical threshold concentration, the targeted
QS genes are activated or repressed. Acyl-homoserine lac-
tone signal-mediated QS systems are the primary QS sys-
tem discovered in gram-negative bacteria. AHL were
originally identified in marine bacteria, where they play a
pivotal role in the regulation of bioluminescence in Vibrio
fischeri [2-4]. Bacteria may produce one or more different
AHL, which regulate diverse phenotypes, such as biofilm
formation, swarming, production of proteases, antibiotics,
siderophores or bioluminescence, conjugation, the modu-
lation of the immune system and the induction of apop-
tosis [5-11]. While AHL are responsible for intraspecies
communication, a second Autoinducer (AI-2) was discov-
ered, which is responsible for the interspecies communica-
tion; furanosyl borate diester is synthezised by the gene
luxS, which is found in the genome of many gram-
negative as well as gram-positive bacteria. It is an integral
component of the activated methyl cycle, which detoxifies
S-adenosyl-L-Methionine (SAM) [12-14].
Probiotics are, according to the FAO/WHO “live bac-
teria which when administered in adequate amounts
confer to a health benefit to the host”. The numerous
mechanisms of the probiotic acting microorganisms in-
clude induced expression of certain cytokines, as well as
increased secretion of immunoglobulin A and mucin, ac-
tivation of lymphocytes and macrophages and inhibition
of the adhesion and invasion of epithelial cells [15].
Escherichia coli Nissle 1917 (Mutaflor) is one of the most
extensively studied probiotic bacterium. It was isolated in
1917 by Prof. Nissle from feces from a soldier during the
First World War, who did not suffer from diarrhoea as
his comrades did. Prof. Nissle realized the potential
health benefits early on [16]. In addition, several import-
ant discoveries were made during recent years: E. coli
Nissle is inducing human ß-defensin 2 (hBD-2) expres-
sion in the cell culture in a time and density dependent
manner [17]. In another study it has been shown that
E. coli Nissle is decreasing TNF-α secretion [18]. Also,
E. coli Nissle is outcompeting several nonpathogenic and
pathogenic bacteria including ETEC and EPEC strains in
biofilm formation [19]. Maintaining remission in ul-
cerative colitis using E. coli Nissle have shown equiva-
lent efficacy to the gold standard mesalazine [20-22].
However, the exact mechanisms by which E. coli Nissleis exerting its beneficial effects are still not completely
understood [23].
If E. coli Nissle is using QS to communicate with itself
or with other species has not been elucidate so far. In
this report we want to elucidate whether or not this bac-
terium is using QS. For the first time we were able to
show that E. coli Nissle is producing AI-2 in a density
dependent manner. We silenced the luxS gene by intron
insertion and studied the effect of QS in the DSS mouse
model of acute colitis. We observed differential expression
of different cytokines and mBD-1, suggesting that indeed
QS is influencing the probiotic properties of E. coli Nissle.
Materials and methods
Animals
Female C57BL/6 J (B6) mice (6–8 weeks of age) were
purchased from Harlan Winkelmann (Borchen, Germany)
and were kept under SPF conditions. The animals were
handled in strict accordance with good animal practice
and all animal work was approved by an appropriate insti-
tutional review committee (Anzeige vom 01.05.2006
Regierungspräsidium Tübingen).Bacterial strains and growth conditions
The Escherichia coli strain Nissle 1917 (Mutaflor) was
kindly provided to us by Dr. Sonnenborn from Ardey-
pharm (Herdecke, Germany). The luxS mutant of
E. coli Nissle 1917 (E. coli Nissle::luxS) was generated
by intron II insertion using the Targetron System (Sigma
Aldrich, Munich, Germany). Using the sequence of luxS,
PCR primers (Table 1.) were generated to mutate the in-
tron. The mutated intron was cloned into the supplied
vector pACD4K, which was transferred into E. coli Nissle.
The “target site”(insertion site for the intron) of the luxS
gene was determined to be the following sequence: CGAT
ATCTCGCCAATGGGCTGCCGCACCGG – intron –
TTTTTATATGAGTCT. The correct insertion of the
intron in the luxS gene was confirmed by PCR (see
Additional file 1). In addition, experiments were con-
ducted showing that AI-2 was not produced any longer by
its mutant. The strains were routinely grown in Luria-Ber-
tani (LB) broth at 37°C, kanamycin (50 μg/ml) was added
when growing the mutant.
For the mouse experiments, the bacteria were grown
to an OD600 = 1 (~0.8–1.2 × 10
9 CFU/ml) from an over-
night culture diluted 1:100 in LB broth. The bacteria
were collected by centrifugation, washed once in PBS
and were resuspended in 200 ml drinking water (+ 4%
DSS in the course of the experiment) for the mice.
Detection of QS molecules
We attempted to isolate AI-1 molecules as it was
described before [24]. Extraction of culture supernatant
Table 1 Bacterial strains and primers used
Name Sequence (5'!3')

























DH5α [pSB403] DH5α carrying plasmid pSB403
E. coli Nissle 1917 DSM6601; Serovar 06:K5:H1
E. coli Nissle::luxS Nissle mutated in the luxS gene
Vibrio harveyi BB120 Vibrio harveyi wildtype
Vibrio harveyi BB886 Vibrio harveyi AI-1 Sensor
Vibrio harveyi BB170 Vibrio harveyi AI-2 Sensor
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500 μl of AHL concentrate in ethyl acetate. Appropriate
dilutions of the concentrates were loaded on a thin-layer
chromatography (TLC) plate (RP-18 F254S; 20 by 20 cm;
Merck, Darmstadt, Germany) and were run in a mois-
ture chamber containing a mixture of 60% methanol and
40% distilled water for 6 h [25]. After the plate was
dried, it was overlaid with 200 ml of 0.6% soft LB agar
seeded with 20 ml of a logarithmically grown culture of
the lux-based AHL biosensor strain E. coli [pSB403],
which is able to respond to a range of different AHL by
luciferase production (e.g., BHL, HHL, OHHL, and
ODHL) [26]. The incubation was carried out overnightin a moisture chamber at 30°C, and AHLs were detected
via autoradiography.
Autoinducer-2 (AI-2) levels in cell-free culture super-
natant were measured using the Vibrio harveyi bio-
luminescence assay as described previously [13]. Briefly,
the bacteria were grown as described above and cell-free
supernatant was prepared at different time points by
centrifugation of the sample at 10.000 × g for 10 minutes.
The supernatant was immediately frozen at −80°C until
being subjected to AI measurements: a 60 μL aliquot of
each sample was added to 600 μl of the sensor bacter-
ium V. harveyi BB170 (AI-2) or V. harveyi BB886 (AI-1)
(being diluted 1:5.000 after being grown in “AB”
medium) [13] and was incubated at 30°C. Every hour the
bioluminescence was measured using a Wallac Lumin-
ometer (Freiburg, Germany). All measurements were
reported at the three hour incubation period, when the
difference between negative controls and positive con-
trols reached maximal levels. The measurements with
the DH5α [pSB403] sensor bacterium was performed in
a similar fashion, however the luminescence was mea-
sured after overnight incubation.
Experiments with DSS colitis mice
After bacterial decontamination of the intestine with
streptomycin (5 μg/ml in drinking water) for two days
[27], the success of this procedure was monitored by
plating out stool on blood agar, LB agar and McConkey
Agar and incubating them for three days under aerobic
and anaerobic conditions at 37°C. From day three the
bacteria were administered in the drinking water of the
mice, which was replaced every two days. Starting at day
five of the experiment, 4% of DSS was dissolved in the
drinking water to induce acute colitis (Figure 1). The
viability of the bacteria was not affected by the presence
of the DSS, as was checked by plating the suspension on
agar plates. The weight of each mouse was recorded
every day and the whole experiment ended at day nine
when the maximal loss of weight was 15% of their initial
weight. The mice were killed in a CO2 containing atmos-
phere. The large intestine was removed under sterile
conditions. The length of the colon was measured. Stool
was weighted, resuspended, homogenized, diluted and
plated on blood-, LB- and McConkey plates and were
incubated in an anaerobic and aerobic atmosphere at
37°C. To confirm that the isolated bacteria where indeed
E. coli Nissle wild type or mutant, we performed colony
PCR with Nissle specific primers (Table 1). For this we
extracted bacterial DNA by suspending bacterial cell
mass in steril water and incubating the suspension at
95°C for 10 minutes. After centrifugation (5.000 rpm; 5
minutes), the DNA containing supernatant was used for
PCR [28]. The mouse experiments were repeated twice,
each group of mice consisted of three to five mice.
0           1          2           3           4          5                 9   days 








Figure 1 Experimental design of the DSS colitis model. The bacterial decontamination of the mouse intestine was performed by streptomycin
treatment for the first two days of the experiment, followed by oral feeding with E. coli Nissle, E. coli Nissle::luxS or pure drinking water. Acute colitis
was induced by administration of 4% DSS in addition to the bacteria to the drinking water, starting from day five of the experiment.
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mucosa of the colon
To analyze the cytokine and mouse beta defensin-1
(mBD-1) mRNA expression in the colonic mucosa, the
mucosa (about 0.5 cm2) was carefully scraped off the
colon. RNA was isolated using the RNAeasy Minikit
(Qiagen, Hilden, Germany). Isolated RNA was reverse
transcribed with Superscript reverse transcriptase
(Invitrogen, Karlsruhe, Germany), oligodT- and random
hexamer primers (Invitrogen). RT PCR was performed
with the primers denoted in Table 1 using 25 ng of
cDNA template on an ABI Prism 7000 System using the
SYBR green method (Fermentas, St. Leon Rot, Ger-
many). Thermal cycling conditions were: 95°C/10 min
followed by 40 cycles of 92°C/15 s and 60°C/60 s. Detec-
tion of fluorescent signal was performed according to
the recommended protocols for the ABI Prism 7000 Real
Time PCR machine (Applied Biosystems, Foster City,
California, USA) The data was analyzed by the ΔCT
method using GAPDH for normalization (ΔCT=CT
sample
- CT
GAPDH). For each increase in ΔCT (x), the expression
is increased by a factor of 2x [29].
Histological scoring
Colon tissue was fixed in ice-cold neutral buffered 4%
formalin for at least two hours followed by a washing
step in phosphate buffered saline. For cryoprotection the
tissue was treated in a 30% saccharose solution overnight.
Afterwards, the tissue was embedded in paraffin and cut
into 2 μm sections. Samples were stained with hematoxylin
and eosin (H&E) (Merck, Darmstadt, Germany). Sections
were analyzed in a blinded fashion by one pathologist.
Statistical analysis
All data are presented as means ± S.D. Analysis of vari-
ance and students t tests were applied when appropriate.
Results
AI-1/AI-2 production in E. coli Nissle 1917
To elucidate whether or not E. coli Nissle is communi-
cating via QS molecules, we attempted to detect QS
signal molecules. In case of AI-1, we tried to isolate anddetect homoserine lactones. The direct isolation of
AHL from the culture supernatant failed (data not
shown), as did the indirect detection via two different
sensor strains, DH5α [pSB403] and Vibrio harveyi
BB886 (Figure 2A; B): while the number of bacteria
were increasing during the growth phase as shown by
the lines in the diagrams, the luminescence emitted by
the sensor strains was low. Eventhough the lumines-
cence was doubled after six hours of incubation, it still
remained at background level. However, when we
attempted to detect AI-2 from the supernatant of the
bacterial cultures, we were successful. Employing the
AI-2 sensor strain Vibrio harveyi BB170, we detected
furanosyl borate diester in a density dependent manner:
after four hours of incubation, the luminescence was
more than six times the amount (in comparison to the
two hours incubation period). And after six hours the
luminescence was 10-fold higher. Thus, for the first
time, we are able to show that E. coli Nissle is produ-
cing AI-2. In the logarithmic and late logarithmic phase
of the growth curve, the production of AI-2 reached
its maximum. Here the luminescence was more than
10-fold higher than the luminescence of the AI-1 sensor
strain Vibrio harveyi BB886 (Figure 2C). During the
later phases of growth, the AI-2 production is leveling
off again (data not shown). Using specific primers
derived from the E. coli K12 luxS sequence (Table 1),
we were able to amplify the luxS gene from E. coli Nis-
sle (data not shown).
In order to study the effect of AI-2 of E. coli Nissle in
the DSS mouse model of acute colitis, we mutated the
luxS gene by intron insertion. Genotypic and pheno-
typic control experiments confirmed the mutation: the
intron II was inserted into the luxS gene. No AI-2
was detected in the supernatant of the mutant as com-
pared to the corresponding wild type E. coli Nissle
(see Additional file 1).
Colonisation and stability of E. coli Nissle and E. coli
Nissle::luxS in the DSS mouse model of acute colitis
For the first time, we showed that E. coli Nissle is produ-
cing AI-2 molecules. In the next series of experiments, we
    
 



























































   E. coli Nissle 
 
 




























































Figure 2 AI-1 and AI-2 production in E.coli Nissle and E.coli DH5α with the sensor bacteria E.coli DH5α [pSB403] (A), V. harveyi BB886
(B) and V. harveyi BB170 (C). Overnight cultures of E.coli Nissle and E.coli DH5α were diluted 1:100 in LB medium containing 0.5% glucose. At
the given time intervals aliquots were drawn, the bacterial numbers were determined by serial dilutions (lines; right Y-axis). Bacterial supernatants
were obtained by centrifugation and frozen at −80°C. The presence of AI-1 and AI-2 was determined by incubating the respective sensor bacteria
with the supernatants (via the luminescence (bars) – left Y-axis).
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has an influence in mice. For this, we used a DSS model
of acute colitis in female C57/BL6 mice. In a first step, we
performed control experiments to elucidate the effect of
the luxS mutation in comparison to the wild type on the
colonization and stability in mice. The bacteria were sup-
plied in the drinking water of the mice (Figure 3). The rate
of colonization of E. coli Nissle and its correspondent
E. coli Nissle::luxS mutant were very similar as was shown
by diluting and plating the stool on different agar plates
(Figure 3A). To confirm that the isolated bacteria are in-
deed E. coli Nissle, a PCR with Nissle specific primers was
performed. The isolated clones from the plates were either
E. coli Nissle wild type or the E. coli Nissle::luxS mutant;
the Nissle specific PCR was positive, as shown by the a
























Figure 3 Control experiments for colonization (A) and stability (B). At
diluted and plated on agar followed by incubation at 37°C for three days. B
primers (Table 1) was performed on selected bacterial clones. On the left isof experiments we confirmed the stability of the mutant in
the mice: agar plates with and without the antibiotic kana-
mycin were inoculated with clones from mice, which were
fed with the mutant. 100% of the clones were resistant to
kanamycin confirming the stability of the luxS mutation
in the mice during the course of the experiment of nine
days.
Effect of E. coli Nissle and E. coli Nissle::luxS in the DSS
mouse model of acute colitis
The change in weight is a good and easy way to monitor
the health status of mice. The development of colitis will
lead to weight loss due to the inability to absorb nutri-
ents in the intestine. Thus, the weight of each mouse
was measured every day during the course of each





the end of each experiment stool was weighted, homogenized,
acterial colonies were counted (A). Colony PCR with Nissle specific
the molecular weight standard in kilobases (KB) (B).





















Figure 5 Length of the colon. The length of the colon of each
mouse was measured, the average colon lenght was determined
and graphically displayed. * p<0.05 compared to DSS control;
** p<0.1 compared to DSS control.
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the mice being fed with the wild type E. coli Nissle lost
more weight on average than the mice being fed with
the E. coli Nissle::luxS or the mice which received 4%
DSS in their drinking water only. At the end of each ex-
periment the average weight loss of the mice receiving
the E. coli Nissle::luxS mutant or only 4% DSS was simi-
lar. While their weight loss was 5%, the average weight
loss of the mice being fed with E. coli Nissle was 15%
(Figure 4). In respect to the fur and how the mice move,
there was a significant difference between the groups of
mice. The group infected with the wild type E. coli Nissle
looked very sick, with their fur being scrubby and their
movement around the cage being rather erratic.
The colon length is another valuable measurement to
determine the severity of a colitis. During the course of
colitis, the colon is shortened. Compared to the DSS
control, the length of the colon from the mice being
infected with the E. coli Nissle::luxS was significant
longer (p<0.05). The colon of the mice infected with the
wild type E. coli Nissle was longer than the DSS control
(moderate significance p<0.1) (Figure 5).Expression of cytokines and mBD-1 in the DSS mice
It has been shown by a number of authors, that E. coli
Nissle is influencing the expression of cytokines and
defensins [17,30]. Here we elucidated, if AI-2 is influen-
cing their expression. We have chosen a number of cyto-
kines, which are well characterized, both pro- and anti-
inflammatory, and also the mouse defensine mBD-1
[31,32] for analysis. After oral infection of the mice with
E. coli Nissle or its correspondent E. coli Nissle::luxS
mutant, an acute colitis was induced by DSS. Expression
of the pro-inflammatory cytokine Interferon-γ was sup-





























Figure 4 Changes in body weight in the course of the experiment. Th
course of each experiment. “0%” was the weight of the mice, when we sta
percentage value.E. coli Nissle wild type in comparison to the mice being
infected with E. coli Nissle::luxS or not being infected at
all. Significant suppression of the anti-inflammatory
cytokine IL-10 in mice being infected by the mutant in
comparison to the uninfected mice was seen. The sup-
pression was, however not significant in comparison to
the mice been fed with the wild type. In the respect to
the pro inflammatory cytokines IL-6 and TNF-α an
increased expression of about 8 fold was seen in mice
infected with the mutant in comparison with the DSS
control (moderate significance of p<0,1) and the wild
type. The expression of the mBD-1 was suppressed
about 4 fold in mice being infected with the luxS mutant
in comparison to the wild type infected mice (moderate
significance of p<0.1) (Figure 6). We also measured the
expression of cytokines in mice which were not treated
with DSS and bacteria. In these mice the expression of
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 DSS  
E. c. Nissle::luxS






Figure 6 Expression of cytokines and mBD-1 in the colon. After scraping the mucosa from the colon, RNA was isolated, transcribed and a
semiquantitative RT PCR was run using the primers despicted in Table 1. The ΔCT values were determined and graphically displayed. * p<0.05
compared to E. coli Nissle::luxS and DSS control; ** p<0.05 compared to DSS control; # p<0.1 compared to Nissle; #* p<0.1 compared to DSS control.
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The histology of the colon was examined by a single
pathologist in a blinded fashion. A scoring system was
used to evaluate the inflammation. Regions of patchy
inflammations were seen, as denoted by infiltration of
granulocytes (see star). Taken together, no significant
differences in the pathology between the different groups
of mice were seen (Figure 7).
Discussion
E. coli Nissle 1917 is a well established probiotic bacter-
ium. Since its first isolation and description 95 years
ago, the interest in this bacterium has increased steadily.
Especially during the last few years, the understanding
on the mechanisms this bacterium is employing for its
beneficial effects, has increased substantially [23]. How-
ever, the exact mechanism of action still remains to beDSS Control 
E. coli Nissle
Figure 7 Histology of the colon. The paraffin embedded sections of the
by a single pathologist. Patchy inflammation is marked by a star.elucidated to completely “understand” this bacterium.
One important gene regulation mechanism, QS, has, so
far, not been looked at in E. coli Nissle. It is a density
dependent genetic regulatory mechanism which allows
single bacterial cells to measure the concentration of
certain bacterial signal molecules. In case that E. coli
Nissle is using QS, we would like to study its influence
on the probiotic properties of the bacterium.
Not surprisingly, this bacterium, as all other E. coli
strains having been studied so far, is not synthesizing
homoserine lactones (AI-1 molecules) [13]. However, we
showed for the first time, that AI-2 is produced by
E. coli Nissle in a density dependent manner. During the
logarithmic and late logarithmic growth phase the
amount of AI-2 being produced is the largest. This find-
ing suggests, that E. coli Nissle is using interspecies
communication and is “talking” with other bacterialE. coli Nissle::luxS 
* 
colon were stained with H & E and were viewed in a blinded fashion
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Nissle, we silenced the corresponding gene via intron in-
sertion. We performed control experiments and were
able to show, that no AI-2 was produced by the mutant
any longer.
We studied the effect of luxS silencing of E. coli Nissle
in the DSS mouse model of acute colitis. The wild type
E. coli Nissle and the E. coli Nissle::luxS mutant behaved
similar in respect to colonisation and stability, which is
essential in animal experiments. Thus, AI-2 in E. coli
Nissle is not necessary for survival of the bacterium,
otherwise we would not have been able to isolate the
mutant bacterium after days in the mouse intestine.
Measuring the body weight of the mice during the
course of the experiments showed that the mice which
were fed with the wild type E. coli Nissle lost 15% of
their initial weight. The other two groups of mice (E. coli
Nissle::luxS; DSS control) lost on average only 5% of
their weight. In addition, the group of mice fed with the
E. coli Nissle started to lose weight about two days early
than the other two groups. In accordance with these
data, these mice looked sicker: their fur was scrubby and
their movement around the cages was rather erratic. We
can speculate, that E. coli Nissle is fitter than its mutant,
which makes the bacterium more prone for potential
translocation: while under healthy conditions there is
minimal translocation of intestinal bacteria in mesenter-
ial lymph nodes, under inflammatory conditions the epi-
thelial barrier is broken down and intestinal bacteria and
also E. coli Nissle are translocated through the Peyer
patches and the MLN [33]. The length of the colon is
proportional to the level of its inflammation: increasing
levels of inflammation results in shortening of the colon.
The colon of these mice, which received only DSS, were
the shortest, while the colon of the mice, which were
inoculated with E. coli Nissle or its corresponding mu-
tant were longer. To elucidate the effect of the oral in-
fection of mice with E. coli Nissle wild type or its
corresponding luxS mutant on the expression of cyto-
kines, we choose four well characterized pro- and anti-
inflammatory cytokines and one defensine. In mice,
which were fed with the wild type E. coli Nissle, the pro-
inflammatory cytokine IFN-γ, was suppressed in the
colon mucosa, while the anti-inflammatory cytokine IL-
10 was suppressed by E. coli Nissle::luxS. The expression
of the pro-inflammatory cytokines Il-6 and TNF-α was
around 8 fold higher in mice infected with the luxS mu-
tant, than in mice of the other two groups. On the other
hand the expression of mBD-1 was suppressed in the
mice infected with the mutant, in comparison to the
mice which were infected with E. coli Nissle or were not
infected at all. Taken together, we observed significant
differences in the expression of cytokines between the
different groups of mice. Eventhough the results werepartly only moderately significant (p<0.1), we have gen-
erated evidence that AI-2 from E. coli Nissle is indeed
influencing the expression of cytokines and defensins
and thus may influence the probiotic properties. It is
well known that E. coli Nissle is capable of inducing
anti-inflammatory cytokines. Early on it was shown, that
E. coli Nissle is stimulating the epithelial defense in
Caco-2 cells [17]. The same authors showed that
patients with Crohns disease, who have a mutation in
NOD2 have a low level of expression of the defensins
HD-5 and HD-6 [17]. The normal colon mucosa is pro-
ducing human beta-defensin-1 (hBD-1; the homolog to
mBD-1) [34]. The functional importance of defensins
was shown in elegant experiments with HD-5 expressing
transgenic mice. These mice became resistant towards
an infection with salmonellae [35]. While pathogenic
bacteria seem to suppress the production of defensins
probably for self-defense [36], E. coli Nissle is protecting
its host by defensin induction [17,34].
It has been shown in a number of studies that homo-
serine lactones (AI-1) regulate the expression of cyto-
kines and virulence factors, for example in Vibrio
cholerae, Pseudomonas aeruginosa or EHEC [37-39].
However, the influence of AI-2 on the cytokine expres-
sion was discussed only in two reports so far [40,41].
Using microarrays the group showed the differential
regulation of a number of genes involved in the comple-
ment pathway, regulation of cytokine expression and
antigen presentation when infecting RAW264.7 macro-
phages with the wild type Vibrio vulnificus or with the
corresponding luxS mutant.
Is QS also used by other probiotic bacteria? Studies
were published only with bacteria of the genus Lactoba-
cillus. Early on it was shown that Lactobacillus rhamno-
sum GG is communicating via AI-2 molecules [42]. It
was shown that the luxS gene has a clear role in the
acidic stress response; AI-2 activity increased by lower-
ing the pH in a dose dependent manner [43]. A second
probiotic bacterium, L. acidophilum strain La-5, showed
that its supernatant is influencing the AI-2 concentra-
tion and the expression of virulence genes of the entero-
hemorrhagic E. coli (EHEC) 0157:H17 in the gut,
inhibiting its colonization. In addition it was shown, that
the supernatant is reducing the attaching and effacing
lesions in HeLa cells. Also a significant inhibition of bac-
terial adhesion in Hep-2 cells was observed. In elegantly
designed mouse experiments, the authors used slow-
scan CCD cameras to show reduced fecal shedding of
luminescent EHEC constructs when L. acidophilus was
fed additionally [44,45]. Another Lactobacillus species,
L. plantarum was used successfully to inhibit the patho-
genic activity of Pseudomonas aeruginosa. The AHL pro-
duction, as well as the production of elastase and biofilm
was inhibited by L plantarum cultures and filtrates, but
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experiments with L. plantarum, it was shown that its
LamBDCA quorum sensing system is responsible for the
modulation of cytokine response in human PBMC [47].
These studies showed that indeed QS is influencing the
probiotic properties of the studied Lactobacillus species.
In the future, QS in other probiotic species should be
studied, to hopefully confirm that QS is indeed influen-
cing the probiotic properties.
Examining the histologic sections of the colon of the
different groups of mice, we did not observe any signifi-
cant difference between the groups. In contrast to the
histopathology of a chronic inflammation, E. coli Nissle
has no influence in case of an acute DSS induced colitis.
Here one can observe histologic patchy mucosal damage
with the loss of crypts, followed by the acute transmural
infiltration of inflammatory cells. No T- or B-cells are
necessary [48].
In this report we showed for the first time that the
probiotic bacterium E. coli Nissle is producing AI-2
molecules. Here we show that AI-2 is affecting the regu-
lation of cytokine expression in the DSS mouse model of
acute colitis. In comparison to the E. coli Nissle luxS
mutant, the mice which were infected with the wild type
lost more weight, looked sicker regarding their fur and
their lack of movement. On the other hand, mice, which
were infected with the E. coli Nissle::luxS mutant
showed a higher expression of pro inflammatory cyto-
kines, but a reduced expression of the anti-inflammatory
cytokine IL-10 or the mBD-1. Thus, it remains to be
seen if AI-2 is influencing the probiotic properties of this
important bacterium.Additional file
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